Brief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
BRIEF-Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics Oct 16 (Reuters) - POLYPEPTIDE GROUP AG PPGN.S:
DEFINITIVE INTERIM RESULT OF THE PUBLIC TENDER OFFER OF SAMSUNG BIOLOGICS CO., LTD.
SAMSUNG PEPTIDE HOLDS 87.92% OF POLYPEPTIDE SHARE CAPITAL
87.59% OF POLYPEPTIDE SHARES TENDERED INTO OFFER
MINIMUM ACCEPTANCE RATE CONDITION OF OFFER SATISFIED
NO MATERIAL ADVERSE EFFECT CONDITION OF OFFER SATISFIED
SAMSUNG PEPTIDE DECLARES OFFER SUCCESSFUL SUBJECT TO REMAINING CONDITIONS
DEAL COMPLETION EXPECTED END OF 2026 OR Q1 2027
TO HOLD EXTRAORDINARY GENERAL MEETING ON OCT 26, 2026
SAMSUNG PEPTIDE TO PURSUE SQUEEZE-OUT AND DELISTING OF POLYPEPTIDE SHARES
ADDITIONAL ACCEPTANCE PERIOD FOR OFFER FROM OCT 19 TO OCT 30, 2026
Source text: ID:nEQ72gS39a
Further company coverage: PPGN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)